Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Omnichannel In Pharma: Scaling Content Operations Noz Urbina, Urbina Consulting | Monica Mercer, Sanofi Vaccines Pharma companies around the world are working to “go omnichannel.” Medical Affairs, MedInfo, Commercial, Marketing, Regulatory, and SciComm teams are ... September 27, 2023 3:00pm 505(b)(2) 신약 개발 마스터 : 전략적 기본 원칙 및 가교자료 준비시 고려사항 William Salminen Ph.D. DABT PMP VP Premier Consulting ; Seth D. DePuy, PhD Manager, Regulatory Affairs Premier Consulting 505(b)(2) 경로에서 성공적인 신약 개발의 복잡성을 포괄적으로 살펴보게 될 웨비나에 참여해 보세요. 이 웨비나에서는 505(b)(2) 신약 개발을 학습하는데 필수적인 전략적 기본 원칙과 가교자료 준비시 고려사항도 모색합니다. 웨비나의 첫 파트에서는 성공의 전략적... 2 months ago | 49 mins Best Practices of Downstream Protein Purification and Product Concentration Krishnamurthy Venkatesan, Downstream MSAT Lead, Senior Director at Biocon Biologics. Downstream protein purification and product concentration is known to be the most challenging part of the process development. It is also known that t... 2 weeks ago | 41 mins In Vitro Diagnostics for Early Cancer Detection Charlie Chrisawn Exec Director, Program Strategy In Vitro Diagnostics, Michael Edwards Snr Director, Regulatory Affairs Topic : [In Vitro Diagnostics for Early Cancer Detection: The Evolution and Promise of Liquid Biopsy Technology] As liquid biopsies become more commo... 2 months ago | 52 mins In Vitro Diagnostics for Early Cancer Detection Charlie Chrisawn Exec Director, Program Strategy In Vitro Diagnostics, Michael Edwards Snr Director, Regulatory Affairs Topic : [In Vitro Diagnostics for Early Cancer Detection: The Evolution and Promise of Liquid Biopsy Technology] As liquid biopsies become more commo... 2 months ago | 52 mins Mastering 505(b)(2) Drug Development:Strategic Pillars & Bridging Considerations William Salminen Ph.D. DABT PMP VP Premier Consulting ; Seth D. DePuy, PhD Manager, Regulatory Affairs Premier Consulting Join us for a comprehensive webinar that delves into the intricacies of successful drug development under the 505(b)(2) pathway. In addition, this web... 3 months ago | 55 mins Mastering 505(b)(2) Drug Development:Strategic Pillars & Bridging Considerations William Salminen Ph.D. DABT PMP VP Premier Consulting ; Seth D. DePuy, PhD Manager, Regulatory Affairs Premier Consulting Join us for a comprehensive webinar that delves into the intricacies of successful drug development under the 505(b)(2) pathway. In addition, this web... 3 months ago | 55 mins [DIA Europe 2023] DRA – A Key Initiative to Future Proof EU Regulatory Ecosystem Esteban Herrero-Martinez, AbbVie; Nasir Hussain, Gilead; Tony Humphreys, EMA; Hugo Hamel, Health Canada. Watch this exciting discussion on the field of Dynamic Regulatory Assessment (DRA) and witness this significant multi-stakeholder engagement in a pivo... 3 months ago | 67 mins Ruggedness and Robustness in Nitrosamine Analysis from Pharmaceutical Elastomers Jason Creasey, at Maven E&L Ltd and Ank Reumer, at Nelson Labs Presented by Jason Creasey, Managing Director at Maven E&L Ltd and Ank Reumer, Senior Study Director, Quantitative Methods Team at Nelson Labs This w... 3 weeks ago | 109 mins Building an Effective Contamination Control Strategy for Sterile Filtration Morven McAlister, Global Sr. Director, Regulatory and Validation Consultancy at Cytiva The newly revised Annex 1 emphasizes Quality Risk Management (QRM) and highlights how this can inform and direct a contamination control strategy (CCS... November 2, 2023 2:00pm Load more